Cited 0 time in
Streptozotocin-induced diabetes increases the interaction of Bad/BCl-X-L and decreases the binding of pBad/14-3-3 in rat testis
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Koh, Phil-Ok | - |
| dc.date.accessioned | 2022-12-27T06:52:50Z | - |
| dc.date.available | 2022-12-27T06:52:50Z | - |
| dc.date.issued | 2007-09-08 | - |
| dc.identifier.issn | 0024-3205 | - |
| dc.identifier.issn | 1879-0631 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/28284 | - |
| dc.description.abstract | Sexual dysfunction is frequently associated with diabetes in males. The present study was designed to evaluate whether streptozotocin-induced diabetes increases apoptotic cell death in rat testis through the regulation of Bcl-2 family proteins. Diabetes was induced by a single intravenous injection of streptozotocin (40 mg/kg body weight) and testis samples were collected after 3 months. The number of positive cells for TUNEL histochemistry was significantly increased in the testicular germ cells of the diabetic group, compared to those of control. The levels of Bcl-2 and Bcl-X-L, anti-apoptotic proteins, were decreased in the diabetic group. In contrast, the levels of Bax and Bad, pro-apoptotic factors, were increased in the diabetic group, compared with the control group. Moreover, the diabetic condition increased the interaction of Bad and Bcl-X-L, and decreased the binding of pBad and 14-3-3. 14-3-3 acts as an anti-apoptotic factor through interaction with Bad. Our findings suggest that streptozotocin-induced diabetes increases apoptotic cell death in testis tissue through the up-and down-regulation of Bcl-2 family proteins and the interaction of Bad and Bcl-X-L. (C)2007 Elsevier Inc. All rights reserved. | - |
| dc.format.extent | 6 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
| dc.title | Streptozotocin-induced diabetes increases the interaction of Bad/BCl-X-L and decreases the binding of pBad/14-3-3 in rat testis | - |
| dc.type | Article | - |
| dc.publisher.location | 영국 | - |
| dc.identifier.doi | 10.1016/j.lfs.2007.08.017 | - |
| dc.identifier.wosid | 000250188500007 | - |
| dc.identifier.bibliographicCitation | LIFE SCIENCES, v.81, no.13, pp 1079 - 1084 | - |
| dc.citation.title | LIFE SCIENCES | - |
| dc.citation.volume | 81 | - |
| dc.citation.number | 13 | - |
| dc.citation.startPage | 1079 | - |
| dc.citation.endPage | 1084 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Research & Experimental Medicine | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
| dc.subject.keywordPlus | CELL-DEATH | - |
| dc.subject.keywordPlus | INDUCED HYPERGLYCEMIA | - |
| dc.subject.keywordPlus | BCL-2 | - |
| dc.subject.keywordPlus | APOPTOSIS | - |
| dc.subject.keywordPlus | BAX | - |
| dc.subject.keywordPlus | PROTEIN | - |
| dc.subject.keywordPlus | HETERODIMERIZES | - |
| dc.subject.keywordPlus | DYSFUNCTION | - |
| dc.subject.keywordPlus | EXPRESSION | - |
| dc.subject.keywordPlus | PREVENTION | - |
| dc.subject.keywordAuthor | apoptosis | - |
| dc.subject.keywordAuthor | Bcl-2 family protein | - |
| dc.subject.keywordAuthor | rat testis | - |
| dc.subject.keywordAuthor | streptozotocin-induced diabetes | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
